Notice2022-21318
Proposed Data Collection Submitted for Public Comment and Recommendations
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
October 3, 2022
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other federal agencies the opportunity to comment on a continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled the Chronic Disease Self-Management Questionnaire. The questionnaire used for this study will assess Chronic Disease Self- Management participant health behaviors and overall health before and after a six-week workshop.
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 190 (Monday, October 3, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 190 (Monday, October 3, 2022)]
[Notices]
[Pages 59791-59792]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-21318]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-22-1265; Docket No. CDC-2022-0121]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
federal agencies the opportunity to comment on a continuing information
collection, as required by the Paperwork Reduction Act of 1995. This
notice invites comment on a proposed information collection project
titled the Chronic Disease Self-Management Questionnaire. The
questionnaire used for this study will assess Chronic Disease Self-
Management participant health behaviors and overall health before and
after a six-week workshop.
DATES: CDC must receive written comments on or before December 2, 2022.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2022-
0121 by any of the following methods:
<bullet> Federal eRulemaking Portal: <a href="http://www.regulations.gov">www.regulations.gov</a>. Follow
the instructions for submitting comments.
<bullet> Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS H21-8, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to <a href="http://www.regulations.gov">www.regulations.gov</a>.
Please note: Submit all comments through the Federal eRulemaking
portal (<a href="http://www.regulations.gov">www.regulations.gov</a>) or by U.S. mail to the address listed
above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS H21-8, Atlanta, Georgia 30329; Telephone: 404-639-7118;
Email: <a href="/cdn-cgi/l/email-protection#adc2c0cfedcec9ce83cac2db"><span class="__cf_email__" data-cfemail="c3acaea183a0a7a0eda4acb5">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected;
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses; and
5. Assess information collection costs.
Proposed Project
Evaluation of the Chronic Disease Self-Management Program in the US
Affiliated Pacific Islands (OMB Control No. 0920-1265, Exp. 06/30/
2021)--Reinstatement--National Center for Chronic Disease Prevention
and Health Promotion (NCCDPHP), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
NCCDPHP is evaluating the implementation of Stanford University's
Chronic Disease Self-Management Program (CDSMP) in the U.S. Affiliated
Pacific Islands (USAPI). These jurisdictions include American Samoa,
Guam, the Commonwealth of the Northern Mariana Islands, the Republic of
Palau, the Republic of the Marshall Islands, and the Federated States
of Micronesia.
The purpose of the evaluation is: (1) to understand how CDSMP is
being implemented in the region; (2) to identify barriers and
facilitators to implementation; (3) to monitor fidelity to Stanford
University's model and document adaptations to the curriculum; and (4)
to understand the self-reported effects of CDSMP on program
participants. Because this is the first time CDSMP is being implemented
in the USAPI, we do not know if the intervention, which has proven to
improve health outcomes in many ethnic groups within the United States,
will lead to improved health outcomes for these communities. Collecting
this data helps CDC to assess fidelity to and adaptations to the
intervention, and to understand if CDSMP, an evidence-based
intervention, has the same effect in the U.S. Affiliated Pacific
Islands as it has in multiple ethnic groups within the United States.
CDC requests OMB approval for an estimated 95 annual burden hours.
There are no costs to respondents other than their time to participate.
[[Page 59792]]
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per Total burden
Type of respondent Form name respondents responses per response (in (in hr)
respondent hr)
----------------------------------------------------------------------------------------------------------------
Program Participant........... Chronic Disease 190 1 10/60 32
Self-Management
Workshop
Evaluation.
Program Participant........... Chronic Disease 190 2 10/60 63
Self-Management
Questionnaire
(Pre-Post Test).
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 95
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2022-21318 Filed 9-30-22; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on October 3, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.